Rang	Name	Position
1	Mr. Alan H. Auerbach	Founder, Chairman, President, CEO & Secretary
2	Mr. Maximo F. Nougues	CFO & Principal Accounting Officer
3	Mr. Douglas Hunt B.Sc., FRAPS	Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance & Law Officer
4	Mr. Gordon G. Esplin	Chief Accounting Officer
5	Mr. Mariann Ohanesian	Senior Director of Investor Relations
6	Ms. Heather Blaber	Senior Vice President of Marketing
7	Mr. Roger L. Storms	Senior Vice President of Sales
8	Ms. Pamela Wilson BA	Senior Vice President of Clinical Operations
9	Dr. Petra Rietschel	Senior Vice President of Clinical Development
10	Mr. Kenneth Wiehe	Senior Vice President of Supply Chain & Manufacturing

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	7,37%	40,10 Mio. USD
2	American Century Companies Inc	4,49%	24,45 Mio. USD
3	Acadian Asset Management LLC	3,98%	21,64 Mio. USD
4	Renaissance Technologies Corp	3,56%	19,35 Mio. USD
5	Vanguard Capital Management, LLC	3,56%	19,35 Mio. USD
6	Vanguard Portfolio Management, LLC	3,54%	19,24 Mio. USD
7	LSV Asset Management	3,13%	17,05 Mio. USD
8	Dimensional Fund Advisors, Inc.	2,94%	16,00 Mio. USD
9	Geode Capital Management, LLC	2,59%	14,12 Mio. USD
10	O'Shaughnessy Asset Management LLC	2,18%	11,85 Mio. USD
11	State Street Corp	1,84%	10,04 Mio. USD
12	Kennedy Capital Management Inc	1,69%	9,20 Mio. USD
13	Bridgeway Capital Management, LLC	1,53%	8,34 Mio. USD
14	Comprehensive Portfolio Management, LLC	1,45%	7,90 Mio. USD
15	AQR Capital Management LLC	1,40%	7,64 Mio. USD
16	The Goldman Sachs Group Inc	1,30%	7,05 Mio. USD
17	Northern Trust Corp	1,26%	6,88 Mio. USD
18	Connor Clark & Lunn Inv Mgmt Ltd	1,25%	6,78 Mio. USD
19	UBS Group AG	1,23%	6,71 Mio. USD
20	Millennium Management LLC	1,17%	6,35 Mio. USD